Home
Obi Profile
Fees
Services
News
Publications
Contact
You are here:
Title Details
Search
Login
DEUTERATED DERIVATIVES OF IVACAFTOR
No-Receipt date
2017-01821 - 26/05/2017
No-Filing date
20170401444 - 26/05/2017
No-Granting date
3092622 - 28/08/2017
No-EPO application date
12725197.3 - 17/05/2012
No-EPO granting date
2709986 - 22/03/2017
Gazette No-Publication date of application
-
Gazette No-Publication date of granted patent
8/2017 - 23/10/2017
Expiration date
18/05/2032
Kind of title
Validation of European Patent
Legal status
VALID
Priorities
US201161487497 P18/05/2011/US
Active Substance of Supplementary Certificates
-
IPC Classification
Ipc Class
C07D 215/56
C07B 59/00
A61P 11/12
A61K 31/47
Related Documents
Related Titles
Owners
Code
Firstname
Surname
Address
Town
ZIP
Country
1092488
VERTEX PHARMACEUTICALS (EUROPE) LIMITED
2 KINGDOM STREET
LONDON W2 6BD, UNITED KINGDOM
UNITED KINGDOM (GREAT BRITAIN)
Inventors
Code
Firstname
Surname
1897988
MORGAN, ADAM, J.
Representatives
Code
Firstname
Surname
Address
Town
Zip
3464
EFANGELIA
GIAZITZOGLOU "ELENI G. PAPAKONSTANTINOU KAI SYNERGATES, DIKIGORIKI ETAIRIA"
KOUMPARI 2
ATHINA (ATTIKIS)
10674
Contact
Code
Firstname
Surname
Address
Town
Zip
Country
848
EFANGELIA
GIAZITZOGLOU - THOMAIDOU
KOUMPARI 2
ATHINA (ATTIKIS)
10674
GREECE
Owners History
Date
Description
Comments
Data before modification
Data after modification
01/07/2020
Μεταβίβαση (7e802)
Α.Π.4700, ΑΡ.ΥΠ.2739278/4-20, ΔΝΥ704, ΚΩΔ.ΠΛΗΡ.3458. (ΒΕΒΑΙΩΣΗ, βασει κοινοπ. ΕΓΔΕ, αριθμ. MCCCJ/P54528EP/3.1..2018)
770917 Concert Pharmaceuticals Inc. 99 Hayden Avenue ΗΝΩΜΕΝΕΣ ΠΟΛΙΤΕΙΕΣ ΤΗΣ ΑΜΕΡΙΚΗΣ Lexington, MA 02421
1092488 Vertex Pharmaceuticals (Europe) Limited 2 Kingdom Street ΗΝΩΜΕΝΟ ΒΑΣΙΛΕΙΟ (ΜΕΓΑΛΗ ΒΡΕΤΑΝΙΑ) London W2 6BD, UNITED KINGDOM
Title Instruments
Payments history
14 renewals have been done
© OBI all rights reserved
designed & developed by PROFILE S.A.
Certified QMS :
EN ISO 9001:2015
and
ΕΝ ISO 14001:2015
The project "Internet technological information diffusion from industrial property titles" is co-financed 70% by the European Regional Development Found and 30% by the Hellenic public sector (Operational programme "Competitiveness", Measure 4.4).